M.HooverJ.NakamuraR.EcholsR.RittenhouseS.et al
If you are experiencing new symptoms, especially potentially dangerous ones like high blood pressure, one-sided weakness, slurred speech, drooping face, chest pain, shortness of breath, please be evaluated by a doctor to rule out other causes
Prog Neurobiol 131:2164 Laureys G, Clinckers R, Gerlo S, Spooren A, Wilczak N, Kooijman R, Smolders I, Michotte Y, De Keyser J (2010) Astrocytic 2-adrenergic receptors: From physiology to pathology
Zero Measurement Error Consistent, pre-dosed precision ensures accurate experimentation
Pharmacological management of obesity: an Endocrine Society clinical practice guideline
Based on REDEFINE trial populations and the NDA submission terms, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition such as hypertension, dyslipidemia, type 2 diabetes, or obstructive sleep apnea Adults 18 years or older Not pregnant or breastfeeding Contraindications will likely include: personal or family history of MTC or MEN 2 syndrome, prior serious allergic reaction to semaglutide or cagrilintide, and active pancreatitis